Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tammie L.S. Benzinger, M.D., Ph.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis, Missouri, United States
C. Ryan King, M.D., Ph.D.Esther Lu, Ph.D.G. Richard Benzinger, M.D., Ph.D.Hongyu An, Ph.D.Jiayi Huang, M.D.Matthew R Brier, M.D., Ph.D.Qing Wang, Ph.D.Richard Laforest, Ph.D.Tammie L.S. Benzinger, M.D., Ph.D.Yong Wang, Ph.D.Zhude Tu, Ph.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Apr 2026
- Primary completion
- 30 Jun 2031
- Completion
- 30 Jun 2033
- Last update posted
- 21 Apr 2026
- Registered enrollment
- 104
- Registry id
- NCT07462507
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.